CHLORPHENTERMINE S.A. IN THE TREATMENT OF OBESITY AND THE EFFECT OF WEIGHT LOSS ON STEROID EXCRETION.
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D001067:Appetite Depressants; D035843:Biomedical Research; D001826:Body Fluids; D002745:Chlorphentermine; D003692:Delayed-Action Preparations; D004358:Drug Therapy; D005441:Fluids and Secretions; D009765:Obesity; D010600:Pharmacology; D010627:Phenethylamines; D010919:Placebos; D013256:Steroids; D014556:Urine; D015431:Weight Loss
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D001067:Appetite Depressants; D003692:Delayed-Action Preparations; D010627:Phenethylamines; D010919:Placebos; D013256:Steroids; D002745:Chlorphentermine
17-HYDROXYCORTICOSTEROIDS; 17-KETOSTEROIDS; APPETITE DEPRESSANTS; CLINICAL RESEARCH; DELAYED-ACTION PREPARATIONS; DRUG THERAPY; EXCRETION; OBESITY; PHARMACOLOGY; PHENETHYLAMINES; PLACEBOS; URINE